Fineline Cube

Follow:
14481 Articles
Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis
CompanyDrug

Joincare Pharmaceutical Secures NMPA Approval for Triptorelin Microspheres to Treat Endometriosis

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar
CompanyDrug

CSPC Pharmaceutical Secures NMPA Approval for Omalizumab Biosimilar

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development
CompanyDeals

Ningbo Menovo Pharmaceutical Partners with Nanjing Huawe Medicine for High-End Product Development

CSPC Pharmaceutical's ADC CPO301 Earns Second Fast-Track Designation in the US for NSCLC Treatment
CompanyDrug

CSPC Pharmaceutical’s ADC CPO301 Earns Second Fast-Track Designation in the US for NSCLC Treatment

Bio-Thera Solutions Ltd Strikes Licensing Deal with Gedeon Richter for BAT1706 Biosimilar
CompanyDeals

Bio-Thera Solutions Ltd Strikes Licensing Deal with Gedeon Richter for BAT1706 Biosimilar

Jiangsu Aidea Pharmaceutical Secures NMPA Approval for Expanded Indication of Fubangde in HIV Treatment
CompanyDrug

Jiangsu Aidea Pharmaceutical Secures NMPA Approval for Expanded Indication of Fubangde in HIV Treatment

Ascentage Pharma Receives Approval for Two Phase III Trials of APG-2449 in NSCLC
CompanyDrug

Ascentage Pharma Receives Approval for Two Phase III Trials of APG-2449 in NSCLC

MicroPort Endovascular MedTech's Fiber Wool Plug Spring Coil Gains NMPA Marketing Approval
CompanyMedical Device

MicroPort Endovascular MedTech’s Fiber Wool Plug Spring Coil Gains NMPA Marketing Approval

NMPA unveils 83rd GQCE reference drug batch
Policy / Regulatory

NMPA Expands Generic Quality Consistency Evaluation with 83rd Batch of Reference Drugs

Kailera Therapeutics Emerges with USD 400 Million in Series A Funding for Anti-Obesity Pipeline
CompanyDeals

Kailera Therapeutics Emerges with USD 400 Million in Series A Funding for Anti-Obesity Pipeline

AstraZeneca Strikes Exclusive Licensing Deal with CSPC Pharma for Oral Lp(a) Disruptor
CompanyDeals

AstraZeneca Strikes Exclusive Licensing Deal with CSPC Pharma for Oral Lp(a) Disruptor

Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment
CompanyDeals

Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment